Artios Pharma raise 85m in Series B round
Life Sciences Partners and Andera Partners together with Pfizer Ventures and Novartis Venture Fund have put 85m into the cancer drug development company Artios Pharma Ltd.
Author Archive for: TG
About Thomas Gabrielczyk
This author has not written his bio yet.
But we are proud to say that Thomas Gabrielczyk contributed 1081 entries already.
Entries by Thomas Gabrielczyk
Researchers remyelinate neurons
/in News/by Thomas GabrielczykGerman neurogenetics at the Max-Planck-Institute for Experimental Medicine have cured the rare incurable hereditary Charcot-Marie-Tooth disease by simply supplementing the food of mice carrying the disease-causing duplication of the PMP22 gene with […]
Switch for osteoporosis and obesity
/in News/by Thomas GabrielczykGerman researchers have found a molecular switch that determines whether mesenchymal fibroblasts differentiate into fat- or bone-forming cells opening the avenue to modulation of the processes.
Roche presents biomarker test to identify NSCLC responders to Tecentriq
/in News/by Thomas GabrielczykResearchers at Roche’s US arms Genentech and Foundation Medicine Inc. (FMI) presented a liquid biopsy test that can be used to identify NSCLC patients who respond to Roche’s PD-L1 blocker […]
Boehringer Ingelheim starts gene therapy collaboration for cystic fibrosis
/in News/by Thomas GabrielczykGerman pharma company and CDMO Boehringer Ingelheim (BI) steps into the lucrative field of gene therapy. Together with the UK Cystic Fibrosis Gene Therapy Consortium (GTC), BI aims at developing replacement […]
Arix Bioscience acquires 11% stake in Phamaxis Ltd.
/in News/by Thomas GabrielczykAn investor consortium led by British Arix Bioscience plc has put £13.4m into the Australian Pharmaxis Ltd, which develops fibrosis inhibitors based on its amine oxidase discovery platform.
Morphosys launches US subsidiary, appoints lead
/in News/by Thomas GabrielczykMorphosys has named Jennifer Herron President of MorphoSys US Inc. to build up sales presence overseas.
Narasimhan embraces Swiss biotech industry
/in News/by Thomas GabrielczykVas Narasimhan, the newly appointed CEO of Swiss pharma giant Novartis, introduced himself to the Swiss biotech industry with a stimulant talk at the Swiss Biotech Day. Apart from that […]
Business as usual in Amsterdam
/in News/by Thomas GabrielczykThe tremendous success of last years BIO Europe Spring in Barcelona was hard to beat. But the follow-up this year in Amsterdam organised by EBD Group together with Health Holland crystallised […]
Global Bioenergies delivers first batch of cosmetics ingredient
/in News/by Thomas GabrielczykFrench green chemistry specialist Global Bioenergies announced the delivery of a first batch of sustainable cosmetic ingredients to cosmetics heavyweight L’Oréal. It was produced as part of the ISOPROD project, […]